LANGE LOUIS G
SEC insider (Form 3/4/5 filer). CIK 0001238401. Director at NewAmsterdam Pharma Co N.V. (NAMS). 12 reported Form 4/5 transactions since Sep 2024; latest on Mar 11, 2026. Located in NAARDEN, P7.
Companies LANGE LOUIS G has filed insider reports for
- NewAmsterdam Pharma Co N.V. (NAMS): Director
LANGE LOUIS G
CIK: 0001238401
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NewAmsterdam Pharma Co N.V.
Discretionary Trading P&L
Holdings
Transaction History (12 total)
- Mar 11, 2026NAMS
NewAmsterdam Pharma Co N.V.
SaleDirect44.2K shares at avg. $30.41$1.3M - Mar 11, 2026NAMS
NewAmsterdam Pharma Co N.V.
SaleDirect446 shares at avg. $31.23$14K - Mar 9, 2026NAMS
NewAmsterdam Pharma Co N.V.
In-the-MoneyDirect44.6K shares at avg. $11.50$513K - Mar 6, 2026NAMS
NewAmsterdam Pharma Co N.V.
SaleIndirect28.2K shares at avg. $29.41$829K - Jan 7, 2026NAMS
NewAmsterdam Pharma Co N.V.
AwardDirect3.4K shares- - Jun 1, 2025NAMS
NewAmsterdam Pharma Co N.V.
ExerciseIndirect68 shares- - May 1, 2025NAMS
NewAmsterdam Pharma Co N.V.
ExerciseIndirect69 shares- - Apr 14, 2025NAMS
NewAmsterdam Pharma Co N.V.
ExerciseIndirect69 shares- - Mar 26, 2025NAMS
NewAmsterdam Pharma Co N.V.
ExerciseDirect3.1K shares- - Mar 26, 2025NAMS
NewAmsterdam Pharma Co N.V.
AwardDirectRestricted Stock Unit
3.3K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 11, 2026 | NAMS NewAmsterdam Pharma Co N.V. | Sale | 44,173 | $30.41 | $1,343,301 | Direct |
| Mar 11, 2026 | NAMS NewAmsterdam Pharma Co N.V. | Sale | 446 | $31.23 | $13,929 | Direct |
| Mar 9, 2026 | NAMS NewAmsterdam Pharma Co N.V. | In-the-Money | 44,619 | $11.50 | $513,119 | Direct |
| Mar 6, 2026 | NAMS NewAmsterdam Pharma Co N.V. | Sale | 28,186 | $29.41 | $828,950 | Indirect |
| Jan 7, 2026 | NAMS NewAmsterdam Pharma Co N.V. | Award | 3,400 | - | $0 | Direct |
| Jun 1, 2025 | NAMS NewAmsterdam Pharma Co N.V. | Exercise | 68 | - | - | Indirect |
| May 1, 2025 | NAMS NewAmsterdam Pharma Co N.V. | Exercise | 69 | - | - | Indirect |
| Apr 14, 2025 | NAMS NewAmsterdam Pharma Co N.V. | Exercise | 69 | - | - | Indirect |
| Mar 26, 2025 | NAMS NewAmsterdam Pharma Co N.V. | Exercise | 3,102 | - | - | Direct |
| Mar 26, 2025 | NAMS NewAmsterdam Pharma Co N.V. | Award Restricted Stock Unit | 3,308 | - | - | Direct |
1-10 of 12 transactions